美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=APREPITANT"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
APREPITANT 090999 001 ANDA APREPITANT CAPSULE;ORAL 40MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
APREPITANT 090999 002 ANDA APREPITANT CAPSULE;ORAL 80MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
APREPITANT 090999 003 ANDA APREPITANT CAPSULE;ORAL 125MG No No 2012/09/24 2012/09/24 SANDOZ Prescription
FOSAPREPITANT DIMEGLUMINE 203939 001 ANDA FOSAPREPITANT DIMEGLUMINE INJECTABLE;INJECTION 150MG No 2015/05/22 (TA) SANDOZ INC None (Tentative Approval)
FOSAPREPITANT DIMEGLUMINE 206197 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2016/06/09 2016/06/09 FRESENIUS KABI USA Prescription
FOSAPREPITANT DIMEGLUMINE 204845 001 ANDA FOSAPREPITANT DIMEGLUMINE UNKNOWN UNKNOWN No 2017/03/28 (TA) SAGENT PHARMS None (Tentative Approval)
APREPITANT 207777 001 ANDA APREPITANT CAPSULE;ORAL 40MG No No 2017/10/12 2017/10/12 GLENMARK PHARMS SA Prescription
APREPITANT 207777 002 ANDA APREPITANT CAPSULE;ORAL 80MG No No 2017/10/12 2017/10/12 GLENMARK PHARMS SA Prescription
APREPITANT 207777 003 ANDA APREPITANT CAPSULE;ORAL 125MG No No 2017/10/12 2017/10/12 GLENMARK PHARMS SA Prescription
FOSAPREPITANT DIMEGLUMINE 204015 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 115MG BASE/VIAL No No 2019/09/05 2019/09/05 MYLAN LABS LTD Prescription
FOSAPREPITANT DIMEGLUMINE 204015 002 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 MYLAN LABS LTD Prescription
FOSAPREPITANT DIMEGLUMINE 205020 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 APOTEX INC Prescription
FOSAPREPITANT DIMEGLUMINE 209965 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 MSN LABS PVT LTD Prescription
FOSAPREPITANT 210064 001 NDA FOSAPREPITANT DIMEGLUMINE INJECTABLE;INJECTION 150MG/VIAL TBD 2019/09/05 TEVA PHARMS USA INC Prescription
FOSAPREPITANT DIMEGLUMINE 210689 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 LUPIN LTD Prescription
FOSAPREPITANT DIMEGLUMINE 211624 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 SUNGEN PHARMA Prescription
FOSAPREPITANT DIMEGLUMINE 211860 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 BAXTER HLTHCARE CORP Prescription
FOSAPREPITANT DIMEGLUMINE 212309 001 ANDA FOSAPREPITANT DIMEGLUMINE POWDER;INTRAVENOUS EQ 150MG BASE/VIAL No No 2019/09/05 2019/09/05 BE PHARMS Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2019 DrugFuture->U.S. FDA Drugs Database